Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

Image of BioArctic's Logo

BioArctic

The Swedish biopharmaceutical company BioArctic was founded by Prof. Lars Lannfelt and Dr. Pär Gellerfors, to explore important discoveries made by Prof. Lannfelt. These breakthrough discoveries, which have been internationally highly recognized, clarify the central role of protein misfolding in the neurodegenerative disease process in the human brain.

Our common mission

At BioArctic we share a common mission: to provide new and effective treatments for patients with disorders in the central nervous system.

The company's proprietary technology and dedicated personnel have made it possible to develop new immunotherapeutic approaches to neurodegenerative diseases. We focus on therapeutic areas with large unmet medical need such as Alzheimer’s disease, Parkinson’s disease and spinal cord injury.

At BioArctic, we believe that science can alleviate the severe situation for patients suffering from devastating disorders like Alzheimer’s disease and the chronic and progressive movement disorder like Parkinson’s disease. We also know that breakthrough science doesn’t happen in isolation. It happens through outstanding internal collaboration and successful external partnerships. Together with our partners we combine our best efforts, competences, creativities and resources to develop innovative treatment for patients with large unmet medical need.

Privately held and founded in 2003

BioArctic Neuroscience AB (Org. number 556601-2679) a limited Swedish company was founded on January 24, 2003. The company is privately held. On July 14, 2016, the company changed its legal name to BioArctic AB. The company is based in Stockholm, Sweden.Karolinska Innovation AB and Uppsala Universitets Utveckling AB became shareholders in

2004 and 2005, respectively. The founders of BioArctic have remained the largest shareholders.

Mission/Vision

To improve quality of life for patients with Alzheimer´s disease, Parkinson´s disease and Spinal Cord injuries.

Our Values

‍BioArctic´s success is built on vast scientific competence and highly skilled employees who thrive and deliver with great quality.

The company's proprietary technology and dedicated employees have made it possible to develop new immunotherapeutic approaches to neurodegenerative diseases.

We share a common mission: to provide new and effective treatments for patients with disorders in the central nervous system. We focus on therapeutic areas with large unmet medical need such as Alzheimer’s disease, Parkinson’s disease and spinal cord injury.

Our mission underpins everything we do. It reminds us why we exist as a company and helps us deliver on our objectives. It also sets the context for our employees’ activities and the roles of our teams, partners and other collaborators.

Our values guide our decision making, define our beliefs and foster the BioArctic culture.

Our strong commitment to the company values defines the BioArctic culture and helps us execute the strategy in line with our mission.

  • We collaborate
  • We are engaged
  • We act respectfully
  • We take responsibility

Responsible research

Research and innovation are the cornerstones of our business as a biopharmaceutical company. We apply our expertise in science and innovation to some of society’s biggest global public health challenges such as Alzheimer’s and Parkinson’s diseases. We also challenge the urgent need for an innovative treatment of spinal cord injury. To take responsibility is one our core values, but it is also a core part of our long-term business strategy and daily work.

We take responsibility

Code of Conduct

BioArtic creates added value for the company’s stakeholders without compromising with issues related to the environment, work environment and social responsibility. Ethical, social and environmental responsibility is an integrated part of BioArctic’s long term business strategy. The code of conduct describes how the company takes responsibility for the observance of the human rights of those who are affected by the company’s operations and contributes to sustainable development. Read more

Work Environment

The work environment management at BioArctic shall be long-term and preventive in character and seen as a natural part of the operations, of what we do and of the decisions we make. Read more

Diversity

BioArctic’s diversity management implies:

  • To not discriminate
  • To value diversity
  • To manage diversity

BioArctic also regards diversity as a competitive advantage – staffing that reflects society at large generates increased credibility and confidence among our stakeholders, owners and the general public. Read more

Get in touch with us!

Visit us

Warfvinges väg 35
SE-112 51 Stockholm
SWEDEN

Send us mail

Our published articles

No items found.
Date
Title
Category
No articles found.
Image of BioArctic's Logo

BioArctic

The Swedish biopharmaceutical company BioArctic was founded by Prof. Lars Lannfelt and Dr. Pär Gellerfors, to explore important discoveries made by Prof. Lannfelt. These breakthrough discoveries, which have been internationally highly recognized, clarify the central role of protein misfolding in the neurodegenerative disease process in the human brain.

Our common mission

At BioArctic we share a common mission: to provide new and effective treatments for patients with disorders in the central nervous system.

The company's proprietary technology and dedicated personnel have made it possible to develop new immunotherapeutic approaches to neurodegenerative diseases. We focus on therapeutic areas with large unmet medical need such as Alzheimer’s disease, Parkinson’s disease and spinal cord injury.

At BioArctic, we believe that science can alleviate the severe situation for patients suffering from devastating disorders like Alzheimer’s disease and the chronic and progressive movement disorder like Parkinson’s disease. We also know that breakthrough science doesn’t happen in isolation. It happens through outstanding internal collaboration and successful external partnerships. Together with our partners we combine our best efforts, competences, creativities and resources to develop innovative treatment for patients with large unmet medical need.

Privately held and founded in 2003

BioArctic Neuroscience AB (Org. number 556601-2679) a limited Swedish company was founded on January 24, 2003. The company is privately held. On July 14, 2016, the company changed its legal name to BioArctic AB. The company is based in Stockholm, Sweden.Karolinska Innovation AB and Uppsala Universitets Utveckling AB became shareholders in

2004 and 2005, respectively. The founders of BioArctic have remained the largest shareholders.

Mission/Vision

To improve quality of life for patients with Alzheimer´s disease, Parkinson´s disease and Spinal Cord injuries.

Our Values

‍BioArctic´s success is built on vast scientific competence and highly skilled employees who thrive and deliver with great quality.

The company's proprietary technology and dedicated employees have made it possible to develop new immunotherapeutic approaches to neurodegenerative diseases.

We share a common mission: to provide new and effective treatments for patients with disorders in the central nervous system. We focus on therapeutic areas with large unmet medical need such as Alzheimer’s disease, Parkinson’s disease and spinal cord injury.

Our mission underpins everything we do. It reminds us why we exist as a company and helps us deliver on our objectives. It also sets the context for our employees’ activities and the roles of our teams, partners and other collaborators.

Our values guide our decision making, define our beliefs and foster the BioArctic culture.

Our strong commitment to the company values defines the BioArctic culture and helps us execute the strategy in line with our mission.

  • We collaborate
  • We are engaged
  • We act respectfully
  • We take responsibility

Responsible research

Research and innovation are the cornerstones of our business as a biopharmaceutical company. We apply our expertise in science and innovation to some of society’s biggest global public health challenges such as Alzheimer’s and Parkinson’s diseases. We also challenge the urgent need for an innovative treatment of spinal cord injury. To take responsibility is one our core values, but it is also a core part of our long-term business strategy and daily work.

We take responsibility

Code of Conduct

BioArtic creates added value for the company’s stakeholders without compromising with issues related to the environment, work environment and social responsibility. Ethical, social and environmental responsibility is an integrated part of BioArctic’s long term business strategy. The code of conduct describes how the company takes responsibility for the observance of the human rights of those who are affected by the company’s operations and contributes to sustainable development. Read more

Work Environment

The work environment management at BioArctic shall be long-term and preventive in character and seen as a natural part of the operations, of what we do and of the decisions we make. Read more

Diversity

BioArctic’s diversity management implies:

  • To not discriminate
  • To value diversity
  • To manage diversity

BioArctic also regards diversity as a competitive advantage – staffing that reflects society at large generates increased credibility and confidence among our stakeholders, owners and the general public. Read more

Get in touch with us!

Visit us

Warfvinges väg 35
SE-112 51 Stockholm
SWEDEN

Send us mail

Our published articles

No items found.
Date
Title
Category
No articles found.